VERTEX PHARMACEUTICALS INC / MA Depreciation & Amortization 2008-2026 | VRTX
What is depreciation & amortization?
Depreciation and amortization represents the non-cash expense of allocating the cost of tangible and intangible assets over their useful lives.
What is VERTEX PHARMACEUTICALS INC / MA's current depreciation & amortization?
VERTEX PHARMACEUTICALS INC / MA (VRTX) annual depreciation & amortization for 2025 was $209.8M, a 1.25% increase from 2024. VERTEX PHARMACEUTICALS INC / MA depreciation & amortization for the quarter ending March 31, 2026 was $55.9M.
What was VERTEX PHARMACEUTICALS INC / MA's depreciation & amortization in 2024?
VERTEX PHARMACEUTICALS INC / MA annual depreciation & amortization for 2024 was $207.2M, a 14.29% increase from 2023.
What was VERTEX PHARMACEUTICALS INC / MA's depreciation & amortization in 2023?
VERTEX PHARMACEUTICALS INC / MA annual depreciation & amortization for 2023 was $181.3M, a 22.25% increase from 2022.
What is VERTEX PHARMACEUTICALS INC / MA's 5-year depreciation & amortization CAGR?
VERTEX PHARMACEUTICALS INC / MA depreciation & amortization grew at a compound annual growth rate (CAGR) of 13.89% from FY2020 to FY2025, going from $109.5M to $209.8M over 5 years.
Year-over-year comparison from 10-K annual reports
| Period | Value | Change | Source |
|---|---|---|---|
| FY2025 | $209.8M | +1.3% | 10-K |
| FY2024 | $207.2M | +14.3% | 10-K |
| FY2023 | $181.3M | +22.3% | 10-K |
| FY2022 | $148.3M | +18.1% | 10-K |
| FY2021 | $125.6M | +14.7% | 10-K |
| FY2020 | $109.5M | +2.4% | 10-K |
| FY2019 | $106.9M | +47.6% | 10-K |
| FY2018 | $72.4M | +18.0% | 10-K |
| FY2017 | $61.4M | -0.0% | 10-K |
| FY2016 | $61.4M | -1.5% | 10-K |
| FY2015 | $62.3M | -1.4% | 10-K |
| FY2014 | $63.3M | +30.8% | 10-K |
| FY2013 | $48.4M | +26.6% | 10-K |
| FY2012 | $38.2M | +9.0% | 10-K |
| FY2011 | $35.0M | +15.0% | 10-K |
| FY2010 | $30.5M | +1.2% | 10-K |
| FY2009 | $30.1M | -6.5% | 10-K |
| FY2008 | $32.2M | - | 10-K |